Solid Biosciences's market cap is currently ―. The company's EPS TTM is $-10.193; its P/E ratio is -0.37; Solid Biosciences is scheduled to report earnings on May 11, 2023, and the estimated EPS forecast is $-2.27. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 0.00	$ 6.17M	$ 1.93M	$ 3.15M	$ 3.54M
Gross Profit	-	-	-	-	-
EBIT	$ -21.13M	$ -23.86M	$ -25.37M	$ -18.65M	$ -18.03M
EBITDA	$ -20.69M	$ -23.14M	$ -24.66M	$ -17.89M	$ -17.28M
Net Income Common Stockholders	$ -20.41M	$ -25.09M	$ -25.33M	$ -18.61M	$ -17.98M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 142.16M	$ 162.88M	$ 180.05M	$ 207.78M	$ 229.76M
Total Assets	$ 184.47M	$ 208.50M	$ 207.56M	$ 232.38M	$ 248.99M
Total Debt	$ 25.69M	$ 24.99M	$ 1.52M	$ 2.06M	$ 2.27M
Net Debt	$ -116.47M	$ -137.90M	$ -178.53M	$ -205.72M	$ -227.49M
Total Liabilities	$ 41.20M	$ 46.26M	$ 22.05M	$ 24.17M	$ 25.62M
Stockholders Equity	$ 143.28M	$ 162.24M	$ 185.51M	$ 208.21M	$ 223.36M
Cash Flow	-
Free Cash Flow	$ -21.27M	$ -17.01M	$ -27.37M	$ -21.53M	$ -18.66M
Operating Cash Flow	$ -20.43M	$ -15.88M	$ -27.19M	$ -20.87M	$ -18.42M
Investing Cash Flow	$ 14.91M	$ -59.59M	$ 37.74M	$ 30.18M	$ -72.51M
Financing Cash Flow	$ -1.00K	$ 73.00K	$ 22.00K	$ 66.00K	$ 3.00K

Currency in USD

Solid Biosciences Earnings and Revenue History

Income Statement >

Solid Biosciences Debt to Assets

Balance Sheet >

Solid Biosciences Cash Flow

Cash Flow >

Solid Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing